Startup For 10: IngeniumAI

Thanks to Jeff Clark, CEO at IngeniumAI, for providing us with this guest blog as part AI month at techSPARK.

In your own words – what do you do?

Currently, access to specialist radiological expertise is limited, with only a handful of centres spread unevenly across the UK. This often means delayed diagnoses for certain diseases, leading to poorer outcomes. At IngeniumAI, our mission is to detect rare but deadly diseases far earlier by bringing some of the expertise of specialist radiologists into every radiology clinic. We’ve developed software, largely powered by AI, that automatically analyses routine CT scans to flag signs of disease that might otherwise be missed.

What’s the most exciting thing about what you’re doing?

We’re making better use of medical images that are already being collected every day, helping patients get on the right diagnostic pathway much faster. Ultimately, it’s about saving lives by reducing delays to treatment.

What are you most proud of so far?

We recently completed a study with the NHS showing that our software identified disease in patients that had been missed under current clinical practice. Demonstrating clear clinical value is exactly what drives us. With our clinical collaborators, we are about to submit our findings to a peer-reviewed clinical journal to make sure these results are shared widely amongst potential adopters of our technology. On top of that, securing a £300k Innovate UK grant was a huge milestone and a real vote of confidence in what we’re building.

What have you found most difficult about being a startup?

Focus. As a MedTech company, we have to juggle the usual startup challenges with the additional complexity of developing a regulated medical device. Balancing innovation with the strict requirements for certification can be tough with limited resources.

What would you do differently if you started now?

We’d look to build broader clinical partnerships sooner. Being spun out from both the University of Bath and Royal United Hospitals Bath NHS Trust meant we had invaluable clinical input from day one – but if we were starting again, we’d aim to expand those collaborations even earlier.

Where do you think you’ll be in 12 months?

We expect to be moving into partnerships for clinical adoption, accelerating our route to market. Alongside this, we’ll be submitting for regulatory approval as a certified medical device – a key step in our growth.

What excites you most about the future of AI?

How much more easily accessible AI will be as a tool in high quality healthcare. For us, we aim to amplify the skills of clinicians through the use of AI, making healthcare more personalised and efficient.

What tools/people/services/organisations from the cluster have helped you most?

SETSquared has been enormously helpful – and continues to be extremely supportive as we grow.

What’s the best thing about the Bristol & Bath tech cluster?

The energy. There’s so much happening across different sectors and being surrounded by ambitious startups and scaleups creates a genuinely supportive and inspiring community. That was especially clear at TechSPARK’s SPARKies last month: such a fantastic celebration of the cluster!

Where can we find out more about you?

Follow us on LinkedIn where we share regular updates about our journey.